Fidelity Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221M Buy
2,551,476
+38,391
+2% +$3.68M 0.01% 805
2025
Q4
$241M Buy
2,513,085
+145,273
+6% +$14.1M 0.01% 789
2025
Q3
$226M Buy
2,367,812
+746,484
+46% +$68.6M 0.01% 792
2025
Q2
$141M Sell
1,621,328
-725,537
-31% -$61.5M 0.01% 966
2025
Q1
$211M Buy
2,346,865
+241,880
+11% +$21.6M 0.01% 777
2024
Q4
$168M Buy
2,104,985
+265,416
+14% +$23M 0.01% 886
2024
Q3
$166M Buy
1,839,569
+319,256
+21% +$26.9M 0.01% 893
2024
Q2
$120M Buy
1,520,313
+55,712
+4% +$4.57M 0.01% 982
2024
Q1
$128M Buy
1,464,601
+108,180
+8% +$9.23M 0.01% 959
2023
Q4
$112M Sell
1,356,421
-233,620
-15% -$17.8M 0.01% 967
2023
Q3
$125M Buy
1,590,041
+87,412
+6% +$7.32M 0.01% 880
2023
Q2
$132M Sell
1,502,629
-103,345
-6% -$8.9M 0.01% 887
2023
Q1
$129M Buy
1,605,974
+380,590
+31% +$31M 0.01% 894
2022
Q4
$95.2M Sell
1,225,384
-251,957
-17% -$20.4M 0.01% 983
2022
Q3
$119M Buy
1,477,341
+218,840
+17% +$19.7M 0.01% 895
2022
Q2
$113M Sell
1,258,501
-400,141
-24% -$40.5M 0.01% 928
2022
Q1
$184M Buy
1,658,642
+704,032
+74% +$74.4M 0.01% 818
2021
Q4
$98.8M Sell
954,610
-2,645,824
-73% -$306M 0.01% 1108
2021
Q3
$451M Sell
3,600,434
-1,381,961
-28% -$179M 0.04% 459
2021
Q2
$618M Buy
4,982,395
+1,419,785
+40% +$178M 0.05% 367
2021
Q1
$421M Buy
3,562,610
+363,613
+11% +$42.6M 0.04% 489
2020
Q4
$375M Buy
3,198,997
+1,422,620
+80% +$157M 0.03% 489
2020
Q3
$185M Buy
1,776,377
+236,666
+15% +$23.8M 0.02% 658
2020
Q2
$141M Sell
1,539,711
-1,748,732
-53% -$168M 0.02% 739
2020
Q1
$297M Sell
3,288,443
-1,042,922
-24% -$111M 0.04% 385
2019
Q4
$491M Sell
4,331,365
-908,623
-17% -$99.7M 0.05% 322
2019
Q3
$569M Sell
5,239,988
-519
-0% -$54.1K 0.07% 278
2019
Q2
$510M Sell
5,240,507
-1,251,419
-19% -$114M 0.06% 311
2019
Q1
$591M Sell
6,491,926
-1,502,460
-19% -$134M 0.07% 270
2018
Q4
$727M Buy
7,994,386
+1,002,103
+14% +$93.6M 0.1% 186
2018
Q3
$688M Buy
6,992,283
+1,427,704
+26% +$132M 0.08% 243
2018
Q2
$476M Sell
5,564,579
-1,266,337
-19% -$106M 0.05% 333
2018
Q1
$548M Sell
6,830,916
-8,755,031
-56% -$722M 0.07% 314
2017
Q4
$1.26B Sell
15,585,947
-20,998,557
-57% -$1.68B 0.15% 141
2017
Q3
$2.85B Sell
36,584,504
-15,015,381
-29% -$1.25B 0.34% 47
2017
Q2
$4.58B Sell
51,599,885
-5,440,732
-10% -$459M 0.57% 23
2017
Q1
$4.6B Sell
57,040,617
-1,818,110
-3% -$142M 0.58% 20
2016
Q4
$4.19B Sell
58,858,727
-16,513,403
-22% -$1.3B 0.56% 22
2016
Q3
$6.51B Sell
75,372,130
-671,294
-0.9% -$58.5M 0.87% 9
2016
Q2
$6.6B Buy
76,043,424
+264,681
+0.3% +$21.4M 0.9% 9
2016
Q1
$5.68B Sell
75,778,743
-3,102,737
-4% -$234M 0.79% 14
2015
Q4
$6.07B Buy
78,881,480
+1,372,900
+2% +$103M 0.82% 14
2015
Q3
$5.19B Buy
77,508,580
+3,651,755
+5% +$269M 0.74% 16
2015
Q2
$5.47B Buy
73,856,825
+6,117,251
+9% +$467M 0.7% 20
2015
Q1
$5.28B Buy
67,739,574
+21,295,827
+46% +$1.61B 0.67% 18
2014
Q4
$3.35B Buy
46,443,747
+26,286,222
+130% +$1.83B 0.44% 36
2014
Q3
$1.25B Buy
20,157,525
+10,182,583
+102% +$647M 0.17% 126
2014
Q2
$636M Buy
9,974,942
+3,157,120
+46% +$192M 0.09% 265
2014
Q1
$420M Buy
6,817,822
+139,086
+2% +$8.1M 0.06% 362
2013
Q4
$383M Sell
6,678,736
-2,169,550
-25% -$123M 0.05% 375
2013
Q3
$471M Sell
8,848,286
-1,192,459
-12% -$64.2M 0.07% 310
2013
Q2
$517M Buy
+10,040,745
New +$496M 0.08% 277

Other funds holding MDT

Fidelity Investments's MDT Position: Q1 2026 in Review

Fidelity Investments increased its Medtronic (MDT) stake by 1.5% in Q1 2026, buying an estimated $3.68M and bringing the position to 2,551,476 shares worth $221M. The position accounts for 0.01% of the portfolio, ranked #805.

Fidelity Investments first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.6B in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Fidelity Investments held 2,551,476 shares of Medtronic worth $221M as of Q1 2026.
  • Fidelity Investments bought 38,391 Medtronic shares in Q1 2026, an estimated $3.68M.
  • Medtronic made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #805 holding.
  • Fidelity Investments first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Fidelity Investments's Medtronic position peaked at $6.6B in Q2 2016.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.